Navigation Links
AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
Date:6/25/2013

aque and is now starting human studies in pursuit of these same successful results.

About AtheroNova

AtheroNova Inc. is a biotechnology company focused on the discovery, research, development and licensing of novel compounds to safely reduce or regress atherosclerotic plaque deposits and improve lipid profiles in humans. In addition to its lead compound AHRO-001, AtheroNova plans to develop multiple applications for its patented and patents-pending therapies in market sectors that include: Cardiovascular Disease, Stroke, Peripheral Artery Disease, Dementia and Alzheimer's and Erectile Dysfunction, all of which have been linked to atherosclerosis. Atherosclerosis and its related pharmaceutical expenses for these indications cost consumers more than $41 billion annually in the United States alone. For more information, please visit www.AtheroNova.com.

About OOO CardioNova

OOO CardioNova is an operational company in the Russian Federation founded by Maxwell Biotech Group to conduct clinical trials of AHRO-001, seek its approval, and then commercialize it in the territories covered by the license agreement.

About Maxwell Biotech Group

Maxwell Biotech Group is a development partner and financial resource for biotechnology companies. Maxwell provides investment capital and access to an established infrastructure for conducting high-quality clinical trials in Russia, and helps enable the rapid and cost-effective achievement of clinical objectives. Maxwell's unique business model can add value to its partners' pipelines and provide a commercialization path to one of the most lucrative emerging markets. Maxwell relies on an experienced international team of managers and financial and industry experts, with offices in Moscow, Boston and San Diego
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AtheroNova Announces Milestone Filing of IND in Russian Federation
2. AtheroNova Receives Notice of Allowance for Its US Patent Application 12/024,908
3. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
4. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
5. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
6. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
7. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
8. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
9. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
10. ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
11. Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... WHITE PLAINS, N.Y. , July 23, 2014 ... (FDA) approval of idelalisib to treat patients with ... and small lymphocytic lymphoma (SLL) is a significant ... Idelalisib, which goes by the trade ... delta, a protein that is highly expressed in ...
(Date:7/23/2014)... PALO ALTO, Calif., July 23, 2014  Varian Medical ... net earnings of $1.02 per diluted share in the ... negatively impacted by about $0.06 per diluted share due ... a portion of Varian,s existing equity investment in Augmenix, ... Varian,s company-wide revenues totaled $748 million for the third ...
(Date:7/23/2014)... July 23, 2014 UBM Medica US today ... new online community and information resource for neurologists and ... treat their patients with neurological disorders . ... aging population, necessitates greater access to dedicated information for ... on neurological conditions include: , 1 in ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society Applauds FDA's Approval of Idelalisib To Treat Three Types of Blood Cancers 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3
...  Responding to a need for better post-market surveillance of orthopedic ... Consortium of Orthopaedic Registries in October 2010. As ... Journal of Bone and Joint Surgery , ... for improving the safety of orthopedic devices using outcomes registries ...
... Dec. 21, 2011 Senate Democratic Leader John L. ... and CEO of Walgreens Inc., expressing his dismay about ... drug coverage more affordable for many of the low-income ... Walgreens has administered the program through Express Scripts, ...
Cached Medicine Technology:Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 2Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 3Unprecedented International Effort Seeks to Improve Safety of Orthopedic Devices 4
(Date:7/23/2014)... 2014 The National Quality Forum’s ... robust trial for a defined period that will ... relevant quality measures for sociodemographic factors, prior to ... Sociodemographic factors can be socioeconomic, e.g., income, education, ... primary language. Growing evidence shows that sociodemographic ...
(Date:7/23/2014)... young adults living near Sellafield or Dounreay since the ... cancer according to research published in the British ... the Childhood Cancer Research Group at the University of ... 1963 and 2006 among those who were under 25 ... difference was found in cancer incidence from 1991-2006 between ...
(Date:7/23/2014)... Recently, iFitDress.com, a professional company of women’s dresses ... vintage party dresses . Aside from that, it has ... is up to 63% off. , “We are excited to ... items are all manufactured by trustworthy and experienced workers in ... 30; it is great to provide such a great opportunity ...
(Date:7/23/2014)... 2014 Home Care Assistance ... in-home care for seniors, announces the next installment ... experts in a wide range of health and ... clinical social worker and award-winning author Nancy Kriseman, ... caregiver stress and ways to prevent burnout by ...
(Date:7/23/2014)... from the University of Exeter has developed a ... a frequently fatal lung disease which attacks immune ... marrow transplant recipients. , The lateral-flow device (LFD), ... aspergillosis, a notoriously difficult to diagnose disease caused ... , Invasive aspergillosis is a leading cause ...
Breaking Medicine News(10 mins):Health News:NQF Board Approves Trial Period to Test Impact of Risk Adjustment of Performance Measures for Sociodemographic Factors 2Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:New device detects deadly lung disease 2
... Dec. 15 Today, the U.S. Food,and Drug Administration ... along with diet to help lower triglycerides,and LDL cholesterol, ... TRILIPIX is the first and only fibrate to ... In certain patients, treatment guidelines,recommend the combination of a ...
... Matthew L. Myers President, Campaign for Tobacco-Free Kids , ... U.S. Supreme Court today handed down a major victory for ... state consumer protection laws to sue Philip Morris and other ... Today,s ruling poses a significant legal threat to the ...
... Controlling Costs, Improving Quality as Health Care Reform Debate Centers on ... Dec. 15 House Ways and Means Health Subcommittee Chairman ... counsel to Sen. Max Baucus, will join health care expert and ... Future co-director Roger Hickey on a conference call with ...
... Dec. 15 Following is a statement from Michael ... in regards to its financial exposure with Madoff Securities: ... Health System,s financial exposure with Madoff Securities is limited to ... who stipulated that the funds be invested with Madoff. The ...
... Dec. 15 The American Red Cross sheltered hundreds of people ... Northeast. Working with local partners, Red Cross chapters opened shelters in ... , "Unfortunately, ice storms are par for ... is always ready to give people a safe and warm place ...
... Lab study showed it had effect on 60% Of malignant ... produced by the oncogene MYC can stop the spread of ... that has the potential to help cause cancer. , In ... overly active. This causes the ovarian cells to produce excessive ...
Cached Medicine News:Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 2Health News:U.S. Supreme Court Ruling Allowing Light Cigarette Lawsuits Is Victory for Consumers and Health 3Health News:North Shore-LIJ Health System Exposure With Madoff Securities Limited to $5.7M 2Health News:Red Cross Shelters Hundreds as Severe Weather Hits Northeast 2
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Manual Table For Slit Lamp...
Khosla Precision and Quality in Medical and Surgical Products....
Medicine Products: